{"DataElement":{"publicId":"3135381","version":"1","preferredName":"Bladder Carcinoma Clinical Stage","preferredDefinition":"Alphanumeric code to represent the extent of bladder carcinoma within the body, based on clinical assessment of the spread from the original site to other parts of the body, and the staging guidelines from the AJCC edition 7.0.","longName":"3135373v1.0:3135374v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3135373","version":"1","preferredName":"Bladder Carcinoma Clinical Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._Having to do with the examination and treatment of patients._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3135356v1.0:2753330v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3135356","version":"1","preferredName":"Bladder Carcinoma","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","longName":"C4912","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC1173C-8ADA-5FB1-E040-BB89AD432078","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2753330","version":"1","preferredName":"Clinical Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C25398:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E43A631-BCA3-0DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"ONEDATA","dateModified":"2008-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-6311-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3135374","version":"1","preferredName":"Bladder Carcinoma Clinical Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._Having to do with the examination and treatment of patients._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3135374v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage Unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3133771","version":"1","preferredName":"Stage Unknown","longName":"3133771","preferredDefinition":"Not known, not observed, not recorded, or refused.: The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EC079DB-DE3C-1143-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2010-08-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-6367-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Stage IV (T4b, N0, M0  OR Any T, N1-3, M0  OR  Any T, Any N, M1)","ValueMeaning":{"publicId":"3135375","version":"1","preferredName":"Stage IV (T4b, N0, M0  OR Any T, N1-3, M0  OR  Any T, Any N, M1)","longName":"3135375","preferredDefinition":"Stage IV (T4b, N0, M0  OR Any T, N1-3, M0  OR  Any T, Any N, M1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-6371-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-638A-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III (T3a, N0, M0  OR  T3b, N0, M0  OR T4a, N0, M0)","ValueMeaning":{"publicId":"3135376","version":"1","preferredName":"Stage III (T3a, N0, M0  OR  T3b, N0, M0  OR T4a, N0, M0)","longName":"3135376","preferredDefinition":"Stage III (T3a, N0, M0  OR  T3b, N0, M0  OR T4a, N0, M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-6394-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-63AD-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II (T2a, N0, M0  OR  T2b, N0, M0)","ValueMeaning":{"publicId":"3135377","version":"1","preferredName":"Stage II (T2a, N0, M0  OR  T2b, N0, M0)","longName":"3135377","preferredDefinition":"Stage II (T2a, N0, M0  OR  T2b, N0, M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-63B7-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-63D0-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Stage I (T1, N0, M0)","ValueMeaning":{"publicId":"3135378","version":"1","preferredName":"Stage I (T1, N0, M0)","longName":"3135378","preferredDefinition":"Stage I (T1, N0, M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-63DA-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-63F3-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage 0is","valueDescription":"Stage 0is (Tis, N0, M0)","ValueMeaning":{"publicId":"3135379","version":"1","preferredName":"Stage 0is (Tis, N0, M0)","longName":"3135379","preferredDefinition":"Stage 0is (Tis, N0, M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-63FD-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-6416-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Stage 0a","valueDescription":"Stage 0a (Ta, N0, M0)","ValueMeaning":{"publicId":"3135380","version":"1","preferredName":"Stage 0a (Ta, N0, M0)","longName":"3135380","preferredDefinition":"Stage 0a (Ta, N0, M0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-6420-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC04DC3-6439-CF3E-E040-BB89AD43512D","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3130375","version":"1","preferredName":"Bladder Carcinoma Clinical Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.:Having to do with the examination and treatment of patients.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C4912:C25398:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E28D147-6C89-5C69-E040-BB89AD437AFA","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC04DC3-6351-CF3E-E040-BB89AD43512D","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"REEVESD","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Stage","type":"Preferred Question Text","description":"Tumor Stage","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"Clinical or Pathological","url":null,"context":"NCIP"}],"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8FC21DA4-F024-1071-E040-BB89AD43102A","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 9/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}